Back to Search

SURAV SAKYA, MD

MD

Dermatology Physician

NPI: 1760060727Individual

Specialties, Licenses & Credentials

Dermatology PhysicianPrimary

Dermatology

Code: 207N00000X

35.146995(OH)
Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Research & Publications (18)

Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.
PMID 19438227·J Med Chem·2009
7-preclinical
Synthetic approaches to the 2007 new drugs.
PMID 19075810·Mini Rev Med Chem·2008
6-review
Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition.
PMID 18182290·Bioorg Med Chem Lett·2008
7-preclinical
Synthetic approaches to the 2006 new drugs.
PMID 18220978·Mini Rev Med Chem·2007
6-review
Synthetic approaches to the 2005 new drugs.
PMID 17430228·Mini Rev Med Chem·2007
6-review
5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile.
PMID 17126015·Bioorg Med Chem Lett·2007
7-preclinical
5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog.
PMID 16275075·Bioorg Med Chem Lett·2006
7-preclinical
Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.
PMID 16464588·Bioorg Med Chem Lett·2006
7-preclinical
5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure-activity relationship studies of 5-alkylethers and 5-thioethers.
PMID 16380252·Bioorg Med Chem Lett·2006
7-preclinical
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.
PMID 16263283·Bioorg Med Chem Lett·2006
7-preclinical
Synthetic approaches to the 2004 new drugs.
PMID 16375759·Mini Rev Med Chem·2005
6-review
In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor.
PMID 15698798·Bioorg Med Chem·2005
7-preclinical
Synthetic approaches to the 2003 new drugs.
PMID 15579116·Mini Rev Med Chem·2004
6-review
Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.
PMID 14684306·Bioorg Med Chem Lett·2004
7-preclinical
Azalide 3,6-ketals: antibacterial activity and structure-activity relationships of aryl and hetero aryl substituted analogues.
PMID 12657285·Bioorg Med Chem Lett·2003
7-preclinical
Mannopeptimycins, novel antibacterial glycopeptides from Streptomyces hygroscopicus, LL-AC98.
PMID 12175230·J Am Chem Soc·2002
8-other
Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent Gram-positive and Gram-negative antibacterial agents.
PMID 12161150·Bioorg Med Chem Lett·2002
7-preclinical
Synthesis and structure-activity relationships of thiotetronic acid analogues of thiolactomycin.
PMID 11591516·Bioorg Med Chem Lett·2001
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 3 locations total

Address
725 University Blvd
Beavercreek, OH 45324

Locations (3)

Practice Location

725 University Blvd, Beavercreek, OH
(860) 303-9727

Practice Location

2123 AUBURN AVE STE 235, CINCINNATI, OH
(513) 585-3238

Practice Location

7335 YANKEE RD STE 204, LIBERTY TOWNSHIP, OH
(513) 579-9191

Quick Facts

NPI
1760060727
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
3
Publications
18

Are you this provider?

Claim Your Profile